• Enterprise Fellow
• Loughborough University
• T:+44(0)1509 564 826
• E: 

Dr Alex Lyness is an Enterprise Fellow working in Healthcare Engineering and developing novel cell delivery systems. During a brief postdoc role Alex identified the need and requirements of enabling technologies to deliver the cell-based therapies to patients in the clinic. In early 2014, the commercial potential of his research was recognised by the Enterprise Office at Loughborough University and he was awarded an Enterprise Fellowship (£133k) funded by the EPSRC Impact Acceleration Account.

In his role Alex is developing his research into products and assets ready for IP protection by the end of the Fellowship. As an Enterprise Fellow, he also undertakes contract research and development for a number of medtech companies. The most prominent of these current work packages has been for the Cell Therapy Catapult, where he is the Technical Lead on project to develop an intradermal delivery device to deliver a cell-based therapy.

Alex worked on his first medical device, a dry powder inhaler, while at school before gaining two multi-disciplinary engineering degrees, which included industry-sponsored major projects. His PhD was gained after conducting research into the affect of biological variation of skin mechanics has on needle-free drug delivery whilst working at a Oxford-based biotech start-up Glide Technologies (formerly Glide Pharma).

His fellowship was extended in early 2015 after being awarded a further £51k funding after a successful mid-term review.

More details of Alex’s research project